Advertisement

AAPS PharmSciTech

, Volume 19, Issue 8, pp 3481–3489 | Cite as

Microemulsion and Microporation Effects on the Genistein Permeation Across Dermatomed Human Skin

  • Li Chen
  • Manjusha Annaji
  • Sharmila Kurapati
  • William R. Ravis
  • R. Jayachandra Babu
Research Article Theme: Advances in Topical Delivery of Drugs
  • 49 Downloads
Part of the following topical collections:
  1. Theme: Advances in Topical Delivery of Drugs

Abstract

This study reports the microemulsion (ME) effects on the permeation of genistein across normal (intact) and microporated human skin. The genistein formulation was optimized to know the stable ME region in the pseudo-ternary phase diagrams and to maximize the skin permeation and retention of genistein. The phase diagrams were constructed with different oil phases, surfactants, and their combinations. The influence of formulation factors on the permeation through intact and microporated human skin was determined. Based on its wide ME region, as well as permeation enhancement effects, oleic acid was used as an oil phase with various surfactants and co-surfactants to further maximize the ME region and skin permeation. The water content in the formulation played an important role in the ME stability, droplet size, and flux of genistein. For example, the ME with 20% water exhibited 4- and 9-fold higher flux as compared to the ME base (no water) and aqueous suspension, respectively. Likewise, this formulation had demonstrated 2- and 4-fold higher skin retention as compared to the ME base (no water) and aqueous suspension, respectively. The skin microporation did not significantly increase the skin permeation of genistein from ME formulations. The ME composition, water content, and to a lesser extent the ME particle size played a role in improving the skin permeation and retention of genistein.

Keywords

Genistein microemulsion human skin drug delivery, permeation 

Notes

Acknowledgements

This study received financial support from Auburn University Research Initiative in Cancer (AURIC) and the intramural grant program (IGP) from the Auburn University, AL.

Supplementary material

12249_2018_1150_MOESM1_ESM.docx (71 kb)
ESM 1 (DOCX 71 kb)

References

  1. 1.
    Piovesan AC, Soares Júnior JM, Mosquette R, Simões MD, Simões RD, Baracat EC. Morphological and molecular effects of isoflavone and estrogens on the rat mammary gland. Revista Brasileira de Ginecologia e Obstetrícia. 2005;27(4):204–9.CrossRefGoogle Scholar
  2. 2.
    Brand RM, Jendrzejewski JL. Topical treatment with (−)-epigallocatechin-3-gallate and genistein after a single UV exposure can reduce skin damage. J Dermatol Sci. 2008;50(1):69–72.  https://doi.org/10.1016/j.jdermsci.2007.11.008.CrossRefGoogle Scholar
  3. 3.
    Vera JC, Reyes AM, Velasquez F, Rivas CI, Zhang RH, Strobel P, et al. Direct inhibition of the hexose transporter GLUT1 by tyrosine kinase inhibitors. Biochemistry. 2001;40(3):777–90.  https://doi.org/10.1021/bi001660j.CrossRefGoogle Scholar
  4. 4.
    Wei H, Zhang X, Wang Y, Lebwohl M. Inhibition of ultraviolet light-induced oxidative events in the skin and internal organs of hairless mice by isoflavone genistein. Cancer Lett. 2002;185(1):21–9.  https://doi.org/10.1016/s0304-3835(02)00240-9.CrossRefGoogle Scholar
  5. 5.
    Widyarini S, Husband AJ, Reeve VE. Protective effect of the isoflavonoid equol against hairless mouse skin carcinogenesis induced by UV radiation alone or with a chemical cocarcinogen. Photochem Photobiol. 2005;81(1):32–7.  https://doi.org/10.1562/2004-06-02-ra-183.1.CrossRefGoogle Scholar
  6. 6.
    Shyong EQ, Lu Y, Lazinsky A, Saladi RN, Phelps RG, Austin LM, et al. Effects of the isoflavone 4′, 5, 7-trihydroxyisoflavone (genistein) on psoralen plus ultraviolet A radiation (PUVA)-induced photodamage. Carcinogenesis. 2002;23(2):317–21.  https://doi.org/10.1093/carcin/23.2.317.CrossRefGoogle Scholar
  7. 7.
    Peak MJ, Peak JG. Solar-ultraviolet-induced damage to DNA. Photo-Dermatology. 1989;6(1):1–5.Google Scholar
  8. 8.
    Beehler BC, Przybyszewski J, Box HB, Kulesz-Martin MF. Formation of 8-hydroxydeoxyguanosine within DNA of mouse keratinocytes exposed in culture to UVB and H2O2. Carcinogenesis. 1992;13(11):2003–7.  https://doi.org/10.1093/carcin/13.11.2003.CrossRefGoogle Scholar
  9. 9.
    Kim SY, Na YJ, Kim D, Kim Y, Kim HM, Hwang SH, et al. Development of estimation methods of skin oxidation and evaluation of anti-oxidative effects of genistein in topical formulations. The Korean Journal of Physiology & Pharmacology. 2012;16(3):205–9.  https://doi.org/10.4196/kjpp.2012.16.3.205.CrossRefGoogle Scholar
  10. 10.
    Foti P, Erba D, Riso P, Spadafranca A, Criscuoli F, Testolin G. Comparison between daidzein and genistein antioxidant activity in primary and cancer lymphocytes. Arch Biochem Biophys. 2005;433(2):421–7.  https://doi.org/10.1016/j.abb.2004.10.008.CrossRefGoogle Scholar
  11. 11.
    Pavese JM, Farmer RL, Bergan RC. Inhibition of cancer cell invasion and metastasis by genistein. Cancer Metastasis Rev. 2010;29(3):465–82.  https://doi.org/10.1007/s10555-010-9238-z.CrossRefGoogle Scholar
  12. 12.
    Chadha G, Sathigari S, Parsons DL, Jayachandra BR. In vitro percutaneous absorption of genistein from topical gels through human skin. Drug Dev Ind Pharm. 2011;37(5):498–505.  https://doi.org/10.3109/03639045.2010.525238.CrossRefGoogle Scholar
  13. 13.
    Silva AP, Nunes BR, De Oliveira MC, Koester LS, Mayorga P, Bassani VL, et al. Development of topical nanoemulsions containing the isoflavone genistein. Die Pharmazie-An International Journal of Pharmaceutical Sciences. 2009;64(1):32–5.  https://doi.org/10.1691/ph.2009.8150.CrossRefGoogle Scholar
  14. 14.
    Del Gaudio P, Russo P, Dorado RR, Sansone F, Mencherini T, Gasparri F, et al. Submicrometric hypromellose acetate succinate particles as carrier for soy isoflavones extract with improved skin penetration performance. Carbohydr Polym. 2017;165:22–9.  https://doi.org/10.1016/j.carbpol.2017.02.025.CrossRefGoogle Scholar
  15. 15.
    Kang KH, Kang MJ, Lee J, Choi YW. Influence of liposome type and skin model on skin permeation and accumulation properties of genistein. J Dispers Sci Technol. 2010;31(8):1061–6.  https://doi.org/10.1080/01932690903224813.CrossRefGoogle Scholar
  16. 16.
    Kitagawa S, Inoue K, Teraoka R, Morita SY. Enhanced skin delivery of genistein and other two isoflavones by microemulsion and prevention against UV irradiation-induced erythema formation. Chem Pharm Bull. 2010;58(3):398–401.  https://doi.org/10.1248/cpb.58.398.CrossRefGoogle Scholar
  17. 17.
    Huang ZR, Hung CF, Lin YK, Fang JY. In vitro and in vivo evaluation of topical delivery and potential dermal use of soy isoflavones genistein and daidzein. Int J Pharm. 2008;364(1):36–44.  https://doi.org/10.1016/j.ijpharm.2008.08.002.CrossRefGoogle Scholar
  18. 18.
    Moore JO, Wang Y, Stebbins WG, Gao D, Zhou X, Phelps R, et al. Photoprotective effect of isoflavone genistein on ultraviolet B-induced pyrimidine dimer formation and PCNA expression in human reconstituted skin and its implications in dermatology and prevention of cutaneous carcinogenesis. Carcinogenesis. 2006;27(8):1627–35.  https://doi.org/10.1093/carcin/bgi367.CrossRefGoogle Scholar
  19. 19.
    Andrade LM, de Fátima RC, Maione-Silva L, Anjos JL, Alonso A, Serpa RC, et al. Impact of lipid dynamic behavior on physical stability, in vitro release and skin permeation of genistein-loaded lipid nanoparticles. Eur J Pharm Biopharm. 2014;88(1):40–7.  https://doi.org/10.1016/j.ejpb.2014.04.015.CrossRefGoogle Scholar
  20. 20.
    Busby MG, Jeffcoat AR, Bloedon LT, Koch MA, Black T, Dix KJ, et al. Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men. Am J Clin Nutr. 2002;75(1):126–36.  https://doi.org/10.1093/ajcn/75.1.126.CrossRefGoogle Scholar
  21. 21.
    Rangsimawong W, Wattanasri P, Tonglairoum P, Akkaramongkolporn P, Rojanarata T, Ngawhirunpat T, et al. Development of microemulsions and microemulgels for enhancing transdermal delivery of Kaempferia parviflora extract. AAPS PharmSciTech. 2018;23:2058–67.  https://doi.org/10.1208/s12249-018-1003-6.CrossRefGoogle Scholar
  22. 22.
    Tabosa MA, de Andrade AR, Lira AA, Sarmento VH, de Santana DP, Leal LB. Microemulsion formulations for the transdermal delivery of lapachol. AAPS PharmSciTech. 2018;19(4):1837–46.  https://doi.org/10.1208/s12249-018-0995-2.CrossRefGoogle Scholar
  23. 23.
    Lv X, Liu T, Ma H, Tian Y, Li L, Li Z, et al. Preparation of essential oil-based microemulsions for improving the solubility, pH stability, photostability, and skin permeation of quercetin. AAPS PharmSciTech. 2017;18(8):3097–104.  https://doi.org/10.1208/s12249-017-0798-x.CrossRefGoogle Scholar
  24. 24.
    Panapisal V, Charoensri S, Tantituvanont A. Formulation of microemulsion systems for dermal delivery of silymarin. AAPS PharmSciTech. 2012;13(2):389–99.  https://doi.org/10.1208/s12249-012-9762-y.CrossRefGoogle Scholar
  25. 25.
    Hashem FM, Shaker DS, Ghorab MK, Nasr M, Ismail A. Formulation, characterization, and clinical evaluation of microemulsion containing clotrimazole for topical delivery. AAPS PharmSciTech. 2011;12(3):879–86.  https://doi.org/10.1208/s12249-011-9653-7.CrossRefGoogle Scholar
  26. 26.
    Kantarcı G, Özgüney I, Karasulu HY, Arzık S, Güneri T. Comparison of different water/oil microemulsions containing diclofenac sodium: preparation, characterization, release rate, and skin irritation studies. AAPS PharmSciTech. 2007;8(4):75–81.  https://doi.org/10.1208/pt0804091.CrossRefGoogle Scholar
  27. 27.
    Salerno C, Carlucci AM, Bregni C. Study of in vitro drug release and percutaneous absorption of fluconazole from topical dosage forms. AAPS PharmSciTech. 2010;11(2):986–93.  https://doi.org/10.1208/s12249-010-9457-1.CrossRefGoogle Scholar
  28. 28.
    Kogan A, Garti N. Microemulsions as transdermal drug delivery vehicles. Adv Colloid Interf Sci. 2006;123:369–85.  https://doi.org/10.1016/j.cis.2006.05.014.CrossRefGoogle Scholar
  29. 29.
    Kreilgaard M. Influence of microemulsions on cutaneous drug delivery. Adv Drug Deliv Rev. 2002;54:S77–98.  https://doi.org/10.1016/s0169-409x(02)00116-3.CrossRefGoogle Scholar
  30. 30.
    Dreher F, Walde P, Walther P, Wehrli E. Interaction of a lecithin microemulsion gel with human stratum corneum and its effect on transdermal transport. J Control Release. 1997;45(2):131–40.  https://doi.org/10.1016/s0168-3659(96)01559-3.CrossRefGoogle Scholar
  31. 31.
    Qi X, Qin J, Ma N, Chou X, Wu Z. Solid self-microemulsifying dispersible tablets of celastrol: formulation development, characterization and bioavailability evaluation. Int J Pharm. 2014;472(1–2):40–7.  https://doi.org/10.1016/j.ijpharm.2014.06.019.CrossRefGoogle Scholar
  32. 32.
    Patel MR, Patel RB, Parikh JR, Solanki AB, Patel BG. Effect of formulation components on the in vitro permeation of microemulsion drug delivery system of fluconazole. AAPS PharmSciTech. 2009;10(3):917–23.  https://doi.org/10.1208/s12249-009-9286-2.CrossRefGoogle Scholar
  33. 33.
    Kolli CS, Xiao J, Parsons DL, Babu RJ. Microneedle assisted iontophoretic transdermal delivery of prochlorperazine edisylate. Drug Dev Ind Pharm. 2012;38(5):571–6.  https://doi.org/10.3109/03639045.2011.617753.CrossRefGoogle Scholar
  34. 34.
    Moghadam SH, Saliaj E, Wettig SD, Dong C, Ivanova MV, Huzil JT, et al. Effect of chemical permeation enhancers on stratum corneum barrier lipid organizational structure and interferon alpha permeability. Mol Pharm. 2013;10(6):2248–60.  https://doi.org/10.1021/mp300441c.CrossRefGoogle Scholar
  35. 35.
    Chen L, Tan F, Wang J, Liu F. Microemulsion: a novel transdermal delivery system to facilitate skin penetration of indomethacin. Die Pharmazie. 2012;67(4):319–23.  https://doi.org/10.1692/ph.2012.1150.CrossRefGoogle Scholar
  36. 36.
    Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev. 2012;64:128–37.  https://doi.org/10.1016/j.addr.2012.09.032.CrossRefGoogle Scholar
  37. 37.
    Francoeur ML, Golden GM, Potts RO. Oleic acid: its effects on stratum corneum in relation to (trans) dermal drug delivery. Pharm Res. 1990;7(6):621–7.CrossRefGoogle Scholar
  38. 38.
    Ellaithy HM, El-Shaboury KM. The development of Cutina lipogels and gel microemulsion for topical administration of fluconazole. AAPS PharmSciTech. 2002;3(4):77–85.  https://doi.org/10.1208/pt030435.CrossRefGoogle Scholar
  39. 39.
    Malcolmson C, Satra C, Kantaria S, Sidhu A, Lawrence MJ. Effect of oil on the level of solubilization of testosterone propionate into nonionic oil-in-water microemulsions. J Pharm Sci. 1998;87(1):109–16.  https://doi.org/10.1021/js9700863.CrossRefGoogle Scholar
  40. 40.
    Berner B, Mazzenga GC, Otte JH, Steffens RJ, Juang RH, Ebert CD. Ethanol: water mutually enhanced transdermal therapeutic system II: skin permeation of ethanol and nitroglycerin. J Pharm Sci. 1989;78(5):402–7.  https://doi.org/10.1002/jps.2600780512.CrossRefGoogle Scholar
  41. 41.
    Sarpotdar PP, Zatz JL. Percutaneous absorption enhancement by nonionic surfactants. Drug Dev Ind Pharm. 1986;12(11–13):1625–47.  https://doi.org/10.3109/03639048609042599.CrossRefGoogle Scholar
  42. 42.
    Sarpotdar PP, Zatz JL. Evaluation of penetration enhancement of lidocaine by nonionic surfactants through hairless mouse skin in vitro. J Pharm Sci. 1986;75(2):176–81.  https://doi.org/10.1002/jps.2600750216.CrossRefGoogle Scholar
  43. 43.
    Hu L, Hu Q, Yang J. Enhancement of transdermal delivery of ibuprofen using microemulsion vehicle. Iranian journal of basic medical sciences. 2014;17(10):760–6.Google Scholar
  44. 44.
    Pershing LK, Lambert LD, Knutson K. Mechanism of ethanol-enhanced estradiol permeation across human skin in vivo. Pharm Res. 1990;7(2):170–5.CrossRefGoogle Scholar
  45. 45.
    Megrab NA, Williams AC, Barry BW. Oestradiol permeation across human skin, silastic and snake skin membranes: the effects of ethanol/water co-solvent systems. Int J Pharm. 1995;116(1):101–12.  https://doi.org/10.1016/0378-5173(94)00321-u.CrossRefGoogle Scholar
  46. 46.
    Notman R, Anwar J. Breaching the skin barrier—insights from molecular simulation of model membranes. Adv Drug Deliv Rev. 2013;65(2):237–50.  https://doi.org/10.1016/j.addr.2012.02.011.CrossRefGoogle Scholar
  47. 47.
    Lane ME. Skin penetration enhancers. Int J Pharm. 2013;447(1–2):12–21.  https://doi.org/10.1016/j.ijpharm.2013.02.040.CrossRefGoogle Scholar
  48. 48.
    Pawar KR, Smith F, Kolli CS, Babu RJ. Effect of lipophilicity on microneedle-mediated iontophoretic transdermal delivery across human skin in vitro. J Pharm Sci. 2013;102(10):3784–91.  https://doi.org/10.1002/jps.23694.CrossRefGoogle Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2018

Authors and Affiliations

  • Li Chen
    • 1
  • Manjusha Annaji
    • 1
  • Sharmila Kurapati
    • 1
  • William R. Ravis
    • 1
  • R. Jayachandra Babu
    • 1
  1. 1.Department of Drug Discovery and DevelopmentAuburn UniversityAuburnUSA

Personalised recommendations